Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Diego Cadavid, Michelle Mellion, Raymond Hupperts, Keith R. Edwards, Peter A. Calabresi, Jelena Drulović, Gavin Giovannoni, Hans‐Peter Hartung, Douglas L. Arnold, Elizabeth Fisher,

The Lancet Neurology · 2019 · 185 citations · 24 references

Concepts

References

24